Latest From Biotech Now

2012 Fall Event Preview

agenda

The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention & Exhibition Center in Boston, Mass., wrapped this June. The event hosted a record 25,291 partnering meetings and highlighted a broad array of top-level speakers addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 49 states and 65 countries. See what BIO President and CEO Jim Greenwood Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Prop 37 Promises to Rattle the Entire U.S. Food Chain

No-on-Prop-37-btn

Debate continues on whether or not the labeling of foods derived from biotechnology is needed or helpful.  In a report for the Los Angeles Times, reporter Marc Lifscher puts the issue in context.  As the fight over genetically engineered foods heads for the ballot box, government and academic experts still struggle to find reason in this debate: California could become the first state to require labels on genetically modified, or GMO, food products as parties on both Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Developments in the creation of a single EU Patent System stalled – Again.

Catherine Mcloughlin

By Catherine McLoughlin, specialist solicitor for Biotech and Pharmaceutical Companies, Pannone LLP After 40 years of squabbling it was hoped that the European Union was close to finally establishing a single patent system. Following a decision ending six months of stalemate from the European Council on the location of three patent courts the European Parliament has refused to put the proposal for a single European patent to a vote. This brings further delays to the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Learning the Truth About Clinical Trials

clinical-trial-sanofi

There are currently over 60,000 clinical trials occurring in the United States. These programs not only allow patients to access potentially ground-breaking new therapies, but also help researchers collect valuable data. Many patients have concerns about the risk involved, despite the importance of clinical trials in the drug development process. Common misperceptions can deter patients from seeking out new approaches to treatment that can currently only be found in clinical trials. The Masonic Cancer Center Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , ,

Pharmaceuticals Play a Key Role in Value-Based Care

Dan Leonard

By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have been struggling with how best to achieve the triple aim of better care for individuals, improved health for populations, and slower cost growth. Figuring out the best health care delivery structures and approaches is a complex challenge with many variables and moving parts. That’s why there is a great deal of debate and research into what changes can support the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,